How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?

6 Implementation considerations

The following considerations around implementing the evidence generation process have been identified through working with system partners:

Evidence generation period

  • To collect useful data on post-colonoscopy colorectal cancer rates, the length of data collection will need to be sufficient. Clinical advice suggests that 3 years of follow-up data is appropriate, so companies will need to be efficient in starting data collection.

  • Companies will need to be proactive about contacting national data registries, to ensure that data sharing agreements are in place.

Equalities

  • Data should be collected on ethnicity and analysed to assess any differences in diagnostic accuracy when the AI software is used for people from different ethnic backgrounds.

System considerations

  • When introducing AI-supported polyp detection, care should be taken to ensure that endoscopist skill and experience is not lost or fails to develop.

  • Companies should use dedicated and incentivised research staff, to reduce the burden on non-research staff.

  • Real-world data should be used when possible.

ISBN: [to be added at publication]